Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations.

Histopathology - 1 Dec 2010

Pristauz Gunda, Petru Edgar, Stacher Elvira, Geigl Jochen B, Schwarzbraun Thomas, Tsybrovskyy Oleksiy, Winter Raimund, Moinfar Farid

Abstract excerpt

AIM: To assess the expression of receptors for androgen (AR), oestrogen (ER) and progesterone (PR) as well as human epidermal growth factor receptor type 2 (Her-2/neu) status of breast carcinomas in breast cancer susceptibility gene (BRCA) BRCA1/2 mutation carriers and BRCA1/2 negative tested women. METHODS: One hundred and thirty-five breast cancers in women tested for BRCA1/2 mutations. Screening for BRCA1 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma

Share to Cluster Analysis

Share to Immunohistochemistry

Share to Receptors, Androgen

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 21166701
DOI: 10.1111/j.1365-2559.2010.03724.x

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations.PMID 21166701Read ↗

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study.Semantic proximity Read ↗

Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.Semantic proximity Read ↗

Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic eventsSemantic proximity Read ↗

BRCA2 mutations and androgen receptor expression as independent predictors of outcome of male breast cancer patients.Semantic proximity Read ↗

Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer?Semantic proximity Read ↗

Coordinated expression of oestrogen and androgen receptors in HER2-positive breast carcinomas: impact on proliferative activity.Semantic proximity Read ↗

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.Semantic proximity Read ↗

Assessing the Androgen Receptor Status in Clinicopathologic and Hematologic Characteristics of the Triple-negative Breast CancerSemantic proximity Read ↗

Prognostic value of androgen receptor expression and molecular alterations in metastatic triple-negative or low hormone receptor breast carcinomas.Semantic proximity Read ↗

An androgen receptor regulated gene score is associated with epithelial to mesenchymal transition features in triple negative breast cancersSemantic proximity Read ↗

[Androgen receptor-positive triple negative breast cancer: From biology to therapy].Semantic proximity Read ↗

Androgen Receptor driven gene score identifies tumors with Epithelial to Mesenchymal Transition features in triple negative breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.